Strategic Expansion Koning Health is actively expanding its US footprint with new office spaces and increased commercial presence, presenting opportunities to engage regional distributors, hospital networks, and imaging centers for partnerships and large-scale installations.

Clinical Leadership With appointed Co-Chief Medical Officers and a focus on early detection and improved outcomes, there is a strong opening to collaborate on clinical studies, training programs, and peer-network evangelism to drive adoption among radiologists and oncology departments.

Regulatory Footprint Regulatory approvals across US, Europe, China, Australia, and Canada create multi-region selling points; leverage this to approach multinational hospital groups and cross-border radiology departments seeking unified imaging solutions.

Innovation Pipeline The patented, low-dose Koning Vera Breast CT and future plans for broader applications suggest upsell opportunities to existing imaging sites and potential bundled offerings with service contracts, maintenance, and training.

Funding and Validation Significant venture funding and government grants underscore credibility; target academia, government-funded health programs, and grant-driven procurement cycles to accelerate adoption and pilot programs.